e-learning
resources
Berlin 2001
Monday 24.09.2001
COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Generalized muscle dysfunction in COPD and chronic heart failure independent of disease severity
H. R. Gosker, F. M. E. Franssen, F. Ellens, P. R. Heuts, N. H. M. K. Lencer, E. M. F. Wouters, A. M. W. J. Schols (Maastricht, The Netherlands)
Source:
Annual Congress 2001 - COPD
Session:
COPD
Session type:
Oral Presentation
Number:
1315
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. R. Gosker, F. M. E. Franssen, F. Ellens, P. R. Heuts, N. H. M. K. Lencer, E. M. F. Wouters, A. M. W. J. Schols (Maastricht, The Netherlands). Generalized muscle dysfunction in COPD and chronic heart failure independent of disease severity. Eur Respir J 2001; 16: Suppl. 31, 1315
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Related content which might interest you:
Hyperventilation, reduced muscle strength and pulmonary hypertension are the main determinants of chronic dyspnea in chronic heart failure patients
Source: Annual Congress 2008 - Respiratory muscles in disease
Year: 2008
COPD prevalence in chronic heart failure
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011
Autonomic dysfunction, cardio-pulmonary parameters and masked heart failure in non-severe chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Respiratory diseases, hypoxia and cardiovascular function
Year: 2020
Subclinical cardiac dysfunction in moderate to severe chronic obstructive pulmonary disease (COPD) patients
Source: Annual Congress 2011 - COPD management
Year: 2011
Prevalence of comorbidities in patients with chronic obstructive pulmonary disease in presence of heart failure
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Skeletal muscle dysfunction and the related mechanism in chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Healthcare and treatment of COPD
Year: 2009
The effect of COPD on muscle structure and function
Source: Annual Congress 2006 - COPD: a systemic disease affecting the muscles
Year: 2006
Relationships between exacerbation symptoms, recovery and ischaemic heart disease in COPD
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
The difficulties of functional class heart failure assessment in the patients with concomitant chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
Association between endothelial dysfunction and nutrient consumption in patients with chronic obstructive pulmonary disease and heart failure.
Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD
Year: 2018
The effect of co-existent chronic heart failure (CHF) on lower limb muscle function in COPD: Propensity matched analysis
Source: International Congress 2016 – New insights into pulmonary rehabilitation for chronic lung diseases
Year: 2016
The prevalence of quadriceps weakness in COPD and the relationship with disease severity
Source: Eur Respir J 2010; 36: 81-88
Year: 2010
Chronic obstructive pulmonary disease does not increase the risk of ischaemic heart disease
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009
Acute effects of different levels of continuous positive airway pressure on cardiac autonomic modulation in chronic heart failure and chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Physiotherapeutic evaluation and treatment in the acute setting
Year: 2010
Unrecognised ventricular dysfunction in COPD
Source: Eur Respir J 2012; 39: 51-58
Year: 2012
Unrecognised ventricular dysfunction in COPD
Source: Eur Respir J 2011; 39: 51-58
Year: 2012
Beta-blockade therapy in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure in the presence and absence of pulmonary hypertension
Source: Annual Congress 2010 - COPD: management
Year: 2010
Hypoxia as a risk factor for arrhythmias in patients with chronic obstructive pulmonary disease and heart failure
Source: International Congress 2019 – More and more COPD
Year: 2019
The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept